Clinical Impact of New Viral Hepatitis Data From AASLD 2022*

November 4-8, 2022; Washington, DC

Get up to date on the latest practice-changing viral hepatitis data presented at AASLD 2022. Review key studies on HBV, HCV, and HDV; view on-demand webcasts; listen to the on-demand podcasts; download the slides; and read expert commentaries.

Nancy Reau, MD

Stefan Zeuzem, MD

Slides

Slideset

Key Viral Hepatitis Studies Influencing My Practice Following AASLD 2022

View Slideset

Read expert faculty members’ summaries of HBV, HDV, and HCV studies, including data on HBV therapy during pregnancy, HBV therapeutic vaccines and progress toward an HBV cure, HDV clinical impact and phase III clinical trial updates, and HCV implementation science and current status of the cascade of care.

Nancy Reau, MD

Stefan Zeuzem, MD Released: November 16, 2022